{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:47Z","timestamp":1793293847928,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T00:00:00Z","timestamp":1384387200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s00428-013-1503-4","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T05:08:48Z","timestamp":1384319328000},"page":"117-120","source":"Crossref","is-referenced-by-count":6,"title":["Leser\u2013Tr\u00e9lat syndrome in malignant mesothelioma and pulmonary adenocarcinoma: is the EGFR pathway part of the syndrome?"],"prefix":"10.1007","volume":"464","author":[{"given":"Rikke Karlin","family":"Jepsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Guldhammer","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit Guldhammer","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"issue":"1","key":"1503_CR1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0190-9622(96)90502-2","volume":"35","author":"RA Schwartz","year":"1996","unstructured":"Schwartz RA (1996) Sign of Leser\u2013Trelat. J Am Acad Dermatol 35(1):88\u201395","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1503_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2007.08.008","volume":"26","author":"RL Moore","year":"2008","unstructured":"Moore RL, Devere TS (2008) Dermatol Clin 26(1):17\u201329, vii","journal-title":"Dermatol Clin"},{"key":"1503_CR3","doi-asserted-by":"crossref","unstructured":"Ponti G, Luppi G, Losi L, Giannetti A, Seidenari S (2010) Leser\u2013Trelat syndrome in patients affected by six multiple metachronous primitive cancers. J Hematol Oncol 2010; 3:2. doi: 10.1186\/1756-8722-3-2 .","DOI":"10.1186\/1756-8722-3-2"},{"issue":"25","key":"1503_CR4","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198712173172506","volume":"317","author":"DL Ellis","year":"1987","unstructured":"Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME et al (1987) Melanoma, growth factors, acanthosis nigricans, the sign of Leser\u2013Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 317(25):1582\u20131587","journal-title":"N Engl J Med"},{"key":"1503_CR5","unstructured":"Ruschoff J, Kerr KM, Grote HJ, Middel P, von Heydebreck A, Alves VA, et al. (2012) Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer. Arch Pathol Lab Med Dec 27."},{"issue":"4","key":"1503_CR6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1440-1827.2011.02778.x","volume":"62","author":"Y Enomoto","year":"2012","unstructured":"Enomoto Y, Kasai T, Takeda M, Takano M, Morita K, Kadota E et al (2012) A comparison of epidermal growth factor receptor expression in malignant peritoneal and pleural mesothelioma. Pathol Int 62(4):226\u2013231","journal-title":"Pathol Int"},{"issue":"6","key":"1503_CR7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jso.21901","volume":"104","author":"O Rena","year":"2011","unstructured":"Rena O, Boldorini LR, Gaudino E, Casadio C (2011) Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations. J Surg Oncol 104(6):701\u2013705","journal-title":"J Surg Oncol"},{"issue":"3","key":"1503_CR8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2006.08.015","volume":"54","author":"YK Jeon","year":"2006","unstructured":"Jeon YK, Sung SW, Chung JH, Park WS, Seo JW, Kim CW et al (2006) Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer 54(3):387\u2013398","journal-title":"Lung Cancer"},{"issue":"3","key":"1503_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.lungcan.2009.07.014","volume":"68","author":"HJ Lee","year":"2010","unstructured":"Lee HJ, Xu X, Choe G, Chung DH, Seo JW, Lee JH et al (2010) Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study. Lung Cancer 68(3):375\u2013382","journal-title":"Lung Cancer"},{"issue":"9674","key":"1503_CR10","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(09)60569-9","volume":"373","author":"R Pirker","year":"2009","unstructured":"Pirker R, Pereira JR, Szczesna A, von Pawel J, Krzakowski M, Ramlau R et al (2009) Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial. Lancet 373(9674):1525\u20131531","journal-title":"Lancet"},{"issue":"1","key":"1503_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","volume":"13","author":"R Pirker","year":"2012","unstructured":"Pirker R, Pereira JR, von Pawel J, Krzakowski M, Ramlau R, Park K et al (2012) EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study. Lancet Oncol 13(1):33\u201342","journal-title":"Lancet Oncol"},{"issue":"5","key":"1503_CR12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3892\/ijo.2012.1607","volume":"41","author":"J Kurai","year":"2012","unstructured":"Kurai J, Chikumi H, Hashimoto K, Takata M, Sako T, Yamaguchi K et al (2012) Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma. Int J Oncol 41(5):1610\u20131618","journal-title":"Int J Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1503-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1503-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T17:38:14Z","timestamp":1564681094000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1503-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1503-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}